Categories
Coronavirus News

Sarcopenia Treatment Market Outlook 2020 || Business Overview And Top Company Analysis – Novartis AG, AstaReal AB, Regeneron Pharmaceuticals, Inc., Merck Sharp & Dohme Corp

Sarcopenia Treatment Market

Global Sarcopenia Treatment Market research report estimates a considerable growth of market in percentage during the forecast period of 2020-2026. This report also explains market definitions, classifications, applications, and engagements in the Healthcare industry. In addition, the scope of this market report can be broadened from market scenarios to comparative pricing between major players, cost & profit of the specified market regions. Sarcopenia Treatment Market report is very consistent as all the data and information regarding the Healthcare industry is derived via authentic sources such as websites, journals, annual reports of the companies, and magazines.

Get Exclusive Sample Copy of This Report Here https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-sarcopenia-treatment-market

Global Sarcopenia treatment market is rising gradually with a steady CAGR in the forecast period of 2019-2026. The growing prevalence of sarcopenia by increasing old age population and adoption of sedentary and unhealthy lifestyle is the major factor that contributes in the growth of global sarcopenia treatment market.

Few of the major competitors currently working in the global sarcopenia treatment market are Novartis AG, AstaReal AB, Regeneron Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Biophytis, Metabolic Technologies, Inc., AbbVie Inc., Danone, Pfizer Inc., Abbott, Biogen, GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd, Nestlé, Mitacs, Sanofi, Bayer AG, Amway, Zydus Cadila, Eli Lilly and Company, Radius Health, Inc., MYSURABLE S.R.L., PhaseBio Pharmaceuticals, Inc among others.

Read Complete Details with TOC Here https://www.databridgemarketresearch.com/toc?dbmr=global-sarcopenia-treatment-market

Market Definition: Global Sarcopenia Treatment Market

Sarcopenia is a progressive skeletal muscle disorder. It involves the loss of muscle mass and strength due to natural aging process. This condition affects the gait and overall ability of body to perform normal tasks. According to International Osteoporosis Foundation (IOF), the muscle loss starts from the age of 40. The major causes of sarcopenia could be sedentary lifestyle, malnutrition and unhealthy food intake. The increasing population of people aged more than 60 and the increasing cases of malnutrition worldwide are the major factors augmenting the market growth.

Segmentation: Global Sarcopenia Treatment Market

Sarcopenia Treatment Market : By Treatment

  • Medication
  • Vitamin/ Dietary Supplements
  • Others

Sarcopenia Treatment Market : By Route of Administration

  • Oral
  • Injectable

Sarcopenia Treatment Market: By End Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Sarcopenia Treatment Market : By Distribution Channels

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • Others

Sarcopenia Treatment Market : By Geography

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Key Developments in the Sarcopenia Treatment Market:

  • In April 2019. MYSURABLE S.R.L., has developed mioTest, a system based on effective and scientifically validated tools that identifies the risk of sarcopenia. The system can also assess muscle mass composition including functionality and level of hydration of muscles in a beneficial and non-invasive way
  • In April 2019, PhaseBio Pharmaceuticals, Inc. licensed ImmunoForge, Co. Ltd. the global rights for PB1023, a recombinant GLP-1 analogue used for the treatment of patients with sarcopenia. ImmunoForge, Co. Ltd. is working on a pipeline for development of novel therapies for sarcopenia related diseases. PhaseBio Pharmaceuticals, Inc. will receive development milestone payments and royalty payments on the sales of the product by this licensed agreement

Report range:

  1. The report offers Sarcopenia Treatment Market share appraisals for regional and global levels
  2. To gain detailed overview of parent market
  3. Information about key drivers, restraints, opportunities, and their impact analysis on the Sarcopenia Treatment Market size has been provided.
  4. The study provides an in-depth analysis of the global Sarcopenia Treatment Market and current & future trends to elucidate imminent investment pockets.
  5. Identify growth segments and opportunities in the industry

To Get This Report at an Attractive Cost, Click Here https://www.databridgemarketresearch.com/speak-to-analyst?dbmr=global-sarcopenia-treatment-market

About Data Bridge Market Research:

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Mail: [email protected]

Leave a Reply

Your email address will not be published. Required fields are marked *